Dr. Philip Lammers, MD, MSCI, has been named Chief of Medical Oncology for the Baptist Cancer Center. He came to Baptist Medical Group and Baptist Cancer Center in June 2018 from Meharry Medical College in Nashville, Tennessee, where he served as the Chief of the Division of Hematology/Oncology.
Dr. Lammers received a Master of Science degree in cellular and integrative physiology from Indiana University and a Doctorate of Medicine from Indiana University School of Medicine. He completed his internal medicine residency at Barnes-Jewish Hospital at Washington University in St. Louis, Missouri, and then completed a hematology/oncology clinical fellowship and a Master of Science degree in clinical investigation at Vanderbilt University in Nashville, Tennessee.
The Southwest Oncology Group Breast Cancer Committee’s community oncology representative, Dr. Lammers is a member of the ECOG-ACRIN Cancer Research Group’s Health Equity Committee and the Baptist Memorial Hospital institutional review board. His research has been published in numerous journals, including the Journal of Clinical Oncology.
Since joining the Baptist team, Dr. Lammers has served as the Medical Director for clinical research for the Baptist Cancer Center. He is involved in the Baptist Mid-South National Cancer Institute Community Oncology Research Program grant, and he chairs the Oncology Clinical Trials Committee. He has worked to enhance Baptist’s research affiliation with Vanderbilt through collaborations on several grants, including a recently awarded Leukemia and Lymphoma Society IMPACT grant focused on increasing access to malignant hematology clinical trials in rural areas.
Dr. Lammers will continue to serve as Medical Director of Clinical Research and as the Chief of Medical Oncology. He will work with oncologists across the Baptist system to further develop medical oncology services; enhance disease-specific programming; and enhance participation, collaboration and joint decision making among providers, clinicians and operational leaders.
